Is IMRNW or QYLD a better dividend investment in 2026?

IMRNW currently yields 2339.18% with a 5% 5-year dividend growth rate. QYLD yields 11.92% with -2.1% growth. The better choice depends on your goal: IMRNW offers higher current income.

What is the dividend yield difference between IMRNW and QYLD?

IMRNW has a forward dividend yield of 2339.18% ($2.00/share annually). QYLD yields 11.92% ($2.04/share annually). The yield gap is 2327.26 percentage points.

Home › Compare › IMRNW vs QYLD

IMRNW vs QYLD: Dividend Comparison 2026

IMRNW yields 2339.18% · QYLD yields 11.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 IMRNW wins by $43075570633.33M in total portfolio value

INVESTMENT

TIME HORIZON10 years

IMRNW

● Live price

2339.18%

Share price

$0.09

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$43075570633.35M

Annual income

$39,734,102,642,272,360.00

Full IMRNW calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

11.92%

Share price

$17.15

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.4K

Annual income

$5,659.31

Full QYLD calculator →

Portfolio growth — IMRNW vs QYLD

📍 IMRNW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	IMRNW	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, IMRNW + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

IMRNW pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IMRNW

Annual income on $10K today (after 15% tax)

$198,830.41/yr

After 10yr DRIP, annual income (after tax)

$33,773,987,245,931,504.00/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,013.51/yr

After 10yr DRIP, annual income (after tax)

$4,810.41/yr

At 15% tax rate, IMRNW beats the other by $33,773,987,245,926,692.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IMRNW + QYLD for your $10,000?

IMRNW: 50%QYLD: 50%

100% QYLD50/50100% IMRNW

Portfolio after 10yr

$21537785316.69M

Annual income

$19,867,051,321,139,010.00/yr

Blended yield

92.24%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IMRNW buys

QYLD buys

No recent congressional trades found for IMRNW or QYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricIMRNWQYLD

Forward yield	2339.18% ✓	11.92%
Annual dividend / share	$2.00	$2.04 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$43075570633.35M ✓	$25.4K
Annual income after 10y	$39,734,102,642,272,360.00 ✓	$5,659.31
Total dividends collected	$42841070616.16M ✓	$27.1K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: IMRNW vs QYLD ($10,000, DRIP)

Year	IMRNW Portfolio	IMRNW Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1← crossover	$244,618	$233,918.13	$10,352	$1,192.36	+$234.3K → IMRNW
2	$5,609,462	$5,347,721.02	$10,830	$1,347.57	+$5.60M → IMRNW
3	$120,610,820	$114,608,695.17	$11,460	$1,539.07	+$120.60M → IMRNW
4	$2,432,079,455	$2,303,025,877.36	$12,275	$1,777.84	+$2432.07M → IMRNW
5	$46,004,003,878	$43,401,678,861.20	$13,323	$2,078.95	+$46003.99M → IMRNW
6	$816,480,868,143	$767,256,583,993.93	$14,667	$2,463.34	+$816480.85M → IMRNW
7	$13,600,083,122,647	$12,726,448,593,733.79	$16,396	$2,960.57	+$13600083.11M → IMRNW
8	$212,667,837,578,363	$198,115,748,637,130.90	$18,631	$3,612.97	+$212667837.56M → IMRNW
9	$3,122,867,281,384,664	$2,895,312,695,175,815.50	$21,548	$4,482.15	+$3122867281.36M → IMRNW
10	$43,075,570,633,353,950	$39,734,102,642,272,360.00	$25,398	$5,659.31	+$43075570633.33M → IMRNW

IMRNW vs QYLD: Complete Analysis 2026

IMRNW — Stock

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, Israel, Canada, the United States, and internationally. The company operates through two segments, Research and Development, and Hyperimmune Products. It offers Travelan, an over-the-counter medicine to reduce the risk of travelers’ diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for support digestive health and gastrointestinal tract protection; and Protectyn, an immune supplement to help maintain a healthy digestive function and liver. The company is also developing Travelan (IMM-124E) to reduce the risk of contracting travelers’ diarrhea in the United States, and Travelers’ Diarrhea; and IMM-529, for treating patients suffering from recurring clostridium difficile infection. It has a research agreement with Naval Medical Research Center to develop and clinically evaluate a therapeutic targeting Campylobacter and enterotoxigenic Escherichia coli infections; and a collaboration agreement with the Walter Reed Army Institute of Research to develop an oral therapeutic for shigellosis. Immuron Limited was incorporated in 1994 and is headquartered in Carlton, Australia.

Full IMRNW Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this IMRNW vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IMRNW vs SCHD IMRNW vs JEPI IMRNW vs O IMRNW vs KO IMRNW vs MAIN IMRNW vs XYLD IMRNW vs JEPQ IMRNW vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.